A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma
AbstractBackground. The combination of galunisertib, a transforming growth factor (TGF)-β receptor (R)1 kinase inhibitor, and lomustine was found to have antit
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
21 February 2016
|
| In: |
Neuro-Oncology
Year: 2016, Jahrgang: 18, Heft: 8, Pages: 1146-1156 |
| ISSN: | 1523-5866 |
| DOI: | 10.1093/neuonc/now009 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1093/neuonc/now009 Verlag, Volltext: https://academic.oup.com/neuro-oncology/article/18/8/1146/1751761 
|
| Verfasserangaben: | Alba A. Brandes, Antoine F. Carpentier, Santosh Kesari, Juan M. Sepulveda-Sanchez, Helen R. Wheeler, Olivier Chinot, Lawrence Cher, Joachim P. Steinbach, David Capper, Pol Specenier, Jordi Rodon, Ann Cleverly, Claire Smith, Ivelina Gueorguieva, Colin Miles, Susan C. Guba, Durisala Desaiah, Michael M. Lahn, and Wolfgang Wick |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1581948220 | ||
| 003 | DE-627 | ||
| 005 | 20220815032034.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181016s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/neuonc/now009 |2 doi | |
| 035 | |a (DE-627)1581948220 | ||
| 035 | |a (DE-576)511948220 | ||
| 035 | |a (DE-599)BSZ511948220 | ||
| 035 | |a (OCoLC)1341020035 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Brandes, Alba |e VerfasserIn |0 (DE-588)1169160123 |0 (DE-627)1032792906 |0 (DE-576)511947690 |4 aut | |
| 245 | 1 | 2 | |a A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma |c Alba A. Brandes, Antoine F. Carpentier, Santosh Kesari, Juan M. Sepulveda-Sanchez, Helen R. Wheeler, Olivier Chinot, Lawrence Cher, Joachim P. Steinbach, David Capper, Pol Specenier, Jordi Rodon, Ann Cleverly, Claire Smith, Ivelina Gueorguieva, Colin Miles, Susan C. Guba, Durisala Desaiah, Michael M. Lahn, and Wolfgang Wick |
| 264 | 1 | |c 21 February 2016 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 16.10.2018 | ||
| 520 | |a AbstractBackground. The combination of galunisertib, a transforming growth factor (TGF)-β receptor (R)1 kinase inhibitor, and lomustine was found to have antit | ||
| 700 | 1 | |a Capper, David |d 1979- |e VerfasserIn |0 (DE-588)133950751 |0 (DE-627)558829902 |0 (DE-576)300212402 |4 aut | |
| 700 | 1 | |a Wick, Wolfgang |d 1970- |e VerfasserIn |0 (DE-588)120297736 |0 (DE-627)080586929 |0 (DE-576)186221320 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neuro-Oncology |d Oxford : Oxford Univ. Press, 1999 |g 18(2016), 8, Seite 1146-1156 |h Online-Ressource |w (DE-627)357167341 |w (DE-600)2094060-9 |w (DE-576)318041839 |x 1523-5866 |7 nnas |a A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma |
| 773 | 1 | 8 | |g volume:18 |g year:2016 |g number:8 |g pages:1146-1156 |g extent:11 |a A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/neuonc/now009 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://academic.oup.com/neuro-oncology/article/18/8/1146/1751761 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20181016 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 120297736 |a Wick, Wolfgang |m 120297736:Wick, Wolfgang |d 910000 |d 911100 |e 910000PW120297736 |e 911100PW120297736 |k 0/910000/ |k 1/910000/911100/ |p 19 |y j | ||
| 998 | |g 133950751 |a Capper, David |m 133950751:Capper, David |d 910000 |d 912000 |e 910000PC133950751 |e 912000PC133950751 |k 0/910000/ |k 1/910000/912000/ |p 9 | ||
| 999 | |a KXP-PPN1581948220 |e 3028874784 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Alba A. Brandes, Antoine F. Carpentier, Santosh Kesari, Juan M. Sepulveda-Sanchez, Helen R. Wheeler, Olivier Chinot, Lawrence Cher, Joachim P. Steinbach, David Capper, Pol Specenier, Jordi Rodon, Ann Cleverly, Claire Smith, Ivelina Gueorguieva, Colin Miles, Susan C. Guba, Durisala Desaiah, Michael M. Lahn, and Wolfgang Wick"]},"id":{"doi":["10.1093/neuonc/now009"],"eki":["1581948220"]},"physDesc":[{"extent":"11 S."}],"recId":"1581948220","origin":[{"dateIssuedDisp":"21 February 2016","dateIssuedKey":"2016"}],"relHost":[{"origin":[{"publisher":"Oxford Univ. Press ; Duke University Medical Center","dateIssuedKey":"1999","publisherPlace":"Oxford ; Durham, NC","dateIssuedDisp":"1999-"}],"pubHistory":["1.1999 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 21.07.23"],"id":{"issn":["1523-5866"],"eki":["357167341"],"zdb":["2094060-9"]},"title":[{"title":"Neuro-Oncology","title_sort":"Neuro-Oncology","subtitle":"official journal of the World Federation of Neuro-Oncology"}],"part":{"text":"18(2016), 8, Seite 1146-1156","extent":"11","issue":"8","pages":"1146-1156","volume":"18","year":"2016"},"physDesc":[{"extent":"Online-Ressource"}],"recId":"357167341","disp":"A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastomaNeuro-Oncology"}],"person":[{"display":"Brandes, Alba","role":"aut","given":"Alba","family":"Brandes"},{"family":"Capper","given":"David","role":"aut","display":"Capper, David"},{"family":"Wick","given":"Wolfgang","role":"aut","display":"Wick, Wolfgang"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 16.10.2018"],"title":[{"title_sort":"Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma","title":"A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma"}]} | ||
| SRT | |a BRANDESALBPHASEIIRAN2120 | ||